Hayat Pharmaceutical Industries Company PSC operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hayat Pharmaceutical Industries Company PSC with three other
pharmaceutical manufacturers in Middle East:
Philadelphia Pharmaceuticals Industry Company PSC
sales of 6.80 million Jordanian Dinars [US$9.59 million]
Rosetta Genomics Ltd. (USA)
(35.31 million Israel Shekels [US$10.08 million]
October Pharma SAE
based in Egypt
(288.11 million Egyptian Pounds [US$16.33 million]
Hayat Pharmaceutical Industries Company PSC reported sales of 10.54 million Jordanian Dinars (US$14.86 million)
December of 2016.
a very small
increase of 0.2%
versus 2015, when the company's sales were 10.51 million Jordanian Dinars.
Despite this increase, sales are still
below the level achieved in 2014, when Hayat Pharmaceutical Industries Company PSC
reported sales of 10.89 million Jordanian Dinars.